AMG National Trust Bank grew its stake in shares of Humana Inc. (NYSE:HUM – Free Report) by 106.5% during the third quarter, Holdings Channel.com reports. The institutional investor owned 16,953 shares of the insurance provider’s stock after acquiring an additional 8,744 shares during the quarter. AMG National Trust Bank’s holdings in Humana were worth $4,411,000 at the end of the most recent quarter.
Other large investors have also made changes to their positions in the company. Bridgewater Advisors Inc. increased its stake in Humana by 9.1% during the 3rd quarter. Bridgewater Advisors Inc. now owns 1,131 shares of the insurance provider’s stock worth $284,000 after purchasing an additional 94 shares in the last quarter. China Universal Asset Management Co. Ltd. bought a new position in shares of Humana during the third quarter worth about $261,000. Northern Financial Advisors Inc acquired a new stake in shares of Humana in the third quarter valued at approximately $279,000. Pekin Hardy Strauss Inc. increased its stake in Humana by 0.9% in the 3rd quarter. Pekin Hardy Strauss Inc. now owns 34,888 shares of the insurance provider’s stock valued at $9,077,000 after buying an additional 301 shares during the last quarter. Finally, Synovus Financial Corp raised its holdings in Humana by 2.0% during the third quarter. Synovus Financial Corp now owns 2,278 shares of the insurance provider’s stock worth $593,000 after acquiring an additional 45 shares in the last quarter. Institutional investors own 92.38% of the company’s stock.
Analyst Upgrades and Downgrades
HUM has been the subject of a number of recent analyst reports. Evercore cut their price target on shares of Humana from $260.00 to $180.00 in a research note on Thursday, February 12th. Weiss Ratings reiterated a “sell (d+)” rating on shares of Humana in a report on Thursday, January 22nd. TD Cowen decreased their price objective on shares of Humana from $260.00 to $173.00 and set a “hold” rating on the stock in a report on Friday, February 13th. Sanford C. Bernstein reiterated an “outperform” rating and set a $344.00 target price on shares of Humana in a research note on Tuesday, January 6th. Finally, Royal Bank Of Canada lowered Humana from an “outperform” rating to a “sector perform” rating and decreased their price objective for the company from $322.00 to $189.00 in a report on Thursday, February 12th. Seven equities research analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and four have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $228.48.
Humana Trading Down 0.3%
HUM opened at $189.95 on Friday. The company’s 50 day moving average price is $237.44 and its two-hundred day moving average price is $258.73. The firm has a market capitalization of $22.85 billion, a price-to-earnings ratio of 19.34, a PEG ratio of 2.04 and a beta of 0.44. Humana Inc. has a fifty-two week low of $169.61 and a fifty-two week high of $315.35. The company has a debt-to-equity ratio of 0.70, a current ratio of 2.00 and a quick ratio of 2.02.
Humana (NYSE:HUM – Get Free Report) last issued its quarterly earnings data on Wednesday, February 11th. The insurance provider reported ($3.96) earnings per share for the quarter, topping the consensus estimate of ($4.01) by $0.05. The company had revenue of $32.64 billion for the quarter, compared to analysts’ expectations of $32.08 billion. Humana had a net margin of 0.92% and a return on equity of 11.43%. Humana’s revenue for the quarter was up 11.3% on a year-over-year basis. During the same quarter in the previous year, the firm posted ($2.16) earnings per share. Humana has set its FY 2026 guidance at 9.000-9.000 EPS. As a group, research analysts predict that Humana Inc. will post 16.47 earnings per share for the current year.
Humana Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 24th. Stockholders of record on Friday, March 27th will be given a dividend of $0.885 per share. The ex-dividend date is Friday, March 27th. This represents a $3.54 annualized dividend and a dividend yield of 1.9%. Humana’s dividend payout ratio is 36.05%.
Humana Company Profile
Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.
In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.
Featured Articles
- Five stocks we like better than Humana
- The gold chart Wall Street is terrified of…
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
- New gold price target
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM – Free Report).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.
